Lubiprostone NDC 69339-163

Product information

Brand name (proprietary)

Lubiprostone

Generic name (nonproprietary)

lubiprostone

Active ingredients

Lubiprostone — 24 ug/1

Dosage form

Capsule, Gelatin coated

Route

Oral

Labeler

Natco Pharma USA LLC

Product type

Prescription drug

Marketing category

NDA authorized genericApplication NDA 021908

Marketing start

Oct 17, 2022

Listing expires

Dec 31, 2026

Other FDA classes

Chloride Channel Activators (Mechanism)

Identifiers

Product ID 69339-163_8eaefb22-646d-468c-9b62-a1c8585440e2SPL ID 8eaefb22-646d-468c-9b62-a1c8585440e2SPL set ID 10c7b62d-6c39-453c-8d9a-2f441725bc3bRxCUI 616578, 794639UNII 7662KG2R6KUPC 0369339163177

Pharmacologic class

Chloride Channel Activator

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N469339016317 followed by a unit qualifier and the quantity Copy

Package 69339-0163-17. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Label details couldn’t be retrieved right now. Open the label on DailyMed.

Other NDCs under NDA 021908

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

Showing 20 of 24.